enow.com Web Search

  1. Ad

    related to: thyroid eye disease exophthalmos treatment options

Search results

  1. Results from the WOW.Com Content Network
  2. Graves' ophthalmopathy - Wikipedia

    en.wikipedia.org/wiki/Graves'_ophthalmopathy

    In mild disease, patients present with eyelid retraction. In fact, upper eyelid retraction is the most common ocular sign of Graves' orbitopathy. This finding is associated with lid lag on infraduction (Von Graefe's sign), eye globe lag on supraduction (Kocher's sign), a widened palpebral fissure during fixation (Dalrymple's sign) and an incapacity of closing the eyelids completely ...

  3. Viridian's drug cuts thyroid eye disease symptoms in late ...

    www.aol.com/news/viridian-says-thyroid-eye...

    (Reuters) -Viridian Therapeutics said on Tuesday its experimental treatment helped significantly reduce symptoms of thyroid eye disease (TED) in a late-stage study, setting the stage to become the ...

  4. Graves' disease - Wikipedia

    en.wikipedia.org/wiki/Graves'_disease

    Thyroid-associated ophthalmopathy (TAO), or thyroid eye disease (TED), is the most common extrathyroidal manifestation of Graves' disease. It is a form of idiopathic lymphocytic orbital inflammation , and although its pathogenesis is not completely understood, autoimmune activation of orbital fibroblasts , which in TAO express the TSH receptor ...

  5. Signs and symptoms of Graves' disease - Wikipedia

    en.wikipedia.org/wiki/Signs_and_symptoms_of...

    Patients with Graves' disease can also undergo periods of hypothyroidism (inadequate production of thyroid hormone; see symptoms of hypothyroidism), due to the challenges of finding the right dosage of thyroid hormone suppression and/or supplementation. The body's need for thyroid hormone can also change over time, such as in the first months ...

  6. Teprotumumab - Wikipedia

    en.wikipedia.org/wiki/Teprotumumab

    Teprotumumab-trbw was approved for use in the United States in January 2020, for the treatment of adults with thyroid eye disease (TED). [3] [6]Teprotumumab was first investigated for the treatment of solid and hematologic tumors, including breast cancer, Hodgkin's and non-Hodgkin's lymphoma, non-small cell lung cancer, and sarcoma. [13]

  7. Exophthalmos - Wikipedia

    en.wikipedia.org/wiki/Exophthalmos

    Exophthalmos (also called exophthalmus, exophthalmia, proptosis, or exorbitism) is a bulging of the eye anteriorly out of the orbit. Exophthalmos can be either bilateral (as is often seen in Graves' disease) or unilateral (as is often seen in an orbital tumor). Complete or partial dislocation from the orbit is also possible from trauma or ...

  8. Infiltrative ophthalmopathy - Wikipedia

    en.wikipedia.org/wiki/Infiltrative_ophthalmopathy

    Infiltrative ophthalmopathy is found in 5-10% of patients with Graves disease and resembles exophthalmos, except that the blurry or double vision is acquired because of weakness in the ocular muscles of the eye. [1] [2] In addition, there is no known correlation with the patient's thyroid levels.

  9. Batoclimab - Wikipedia

    en.wikipedia.org/wiki/Batoclimab

    It is being developed to treat myasthenia gravis and thyroid eye disease. [1] [2] [3] References

  1. Ad

    related to: thyroid eye disease exophthalmos treatment options